What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Alliance for Clinical Trials in Oncology

Home
United States
Boston, MA
Alliance for Clinical Trials in Oncology

Alliance develops and conducts cancer clinical trials as part of NCI National Clinical Trials Network

09/09/2025

Register for a public webinar from Alliance researchers on the Best of ASCO 2025 on Monday, Sept. 29, 12-1:30 pm CT. Trial results discussed include some of the latest guidance for people living with colorectal, squamous cell, and renal cell cancers. Registration link: bit.ly/AllianceAtASCO

09/09/2025

New publication alert! Results of Alliance A021202 published in ASCO's Journal of Clinical Oncology show that the drug pazopanib is effective against some neuroendocrine tumors. Pazopanib is a tyrokinase inhibitor that blocks specific proteins that cancer cells need to grow. Read the paper online at https://bit.ly/JCO-A021202.

09/09/2025

New trial! Alliance Revitalize trial A221801 led by Dr. Maryam Lustberg of Yale Cancer Cancer is studying laser therapy for vaginal dryness in breast cancer survivors. Learn more: https://bit.ly/A221801.

09/08/2025

Watch Dana-Farber Cancer Institute Dr. Adrienne Waks' interview with DocWire News about Alliance A012303-ShortStop-HER2 phase III study testing if less treatment after surgery is acceptable for people with early-stage HER2+ breast cancer. Watch the interview at https://bit.ly/ShortStopHER2. Trial information can be found at https://bit.ly/Alliance-A012303.

09/08/2025

Alliance clinical trial A222301 led by Roswell Park's Dr. Anurag Singh is studying the need for op**te pain medication for mouth sores caused by radiation and chemotherapy. Learn more at https://bit.ly/Alliance-A222301

09/05/2025

Did you know that cancer is a genetic disease? Cancer is caused by certain changes to genes that control the way our cells carry out daily jobs, especially how they grow and divide. This information from the National Cancer Institute explains how genetics can increase cancer risk - http://bit.ly/Cancer-Genetics

09/04/2025

Video from Geoffrey Shapiro, M.D., Ph.D., at Dana Farber talks about the courage of clinical trial participants and how his research uses tumor profiling to identify gene mutations to help match people with the best treatments available. https://bit.ly/TrialMatching

09/04/2025

Led by Geoffrey Shapiro, M.D., Ph.D., at Dana Farber Cancer Center, joint Alliance, ECOG-ACRIN, NRG Oncology and SWOG ComboMATCH trial EAY191-A3 is enrolling patients with RAS-mutated cancers to test effectiveness of enzyme blockers called kinase inhibitors. Learn more: https://bit.ly/EAY191-A3

09/03/2025

Aaron Mansfield, MD, of the Mayo Clinic is leading Alliance A092001 trial comparing the usual treatment alone to using immunotherapy plus the usual treatment in treating patients with aggressive abdominal cancer. Learn more: https://bit.ly/Alliance-A092001

09/03/2025

: Alliance A032303 (GAIN-BCG) is a trial led by Eugene Pietzak, MD, of Memorial Sloan Kettering Cancer Center, evaluating a two-stage treatment approach for patients with high-risk, non–muscle-invasive bladder cancer (NMIBC) that has come back and did not respond to BCG treatment. To learn more about the trial, visit https://bit.ly/Alliance-A032303

09/02/2025

The trial is enrolling patients with that has spread beyond the liver. Patients who responded well to initial chemo & have up to four treatable cancer sites be eligible to participate. Learn more: https://bit.ly/Alliance-A022101 Fight Colorectal Cancer Colontown - Here With You.

09/01/2025

- a phase III trial is currently enrolling to evaluate pain management strategies for patients undergoing chemoradiation for head and neck cancer?

Alliance A222301 (HOPE Study), led by Anurag Singh, MD, of Roswell Park Comprehensive Cancer Center, is studying whether high-dose prophylactic gabapentin reduces the need for opioid medications in patients experiencing oral mucositis, a common side effect of treatment for squamous cell carcinoma of the head and neck.

The study aims to assess differences in pain control and opioid use, along with other treatment-related outcomes. Learn more about this study: https://bit.ly/Alliance-A222301

Address

Alliance For Clinical Trials In Oncology, Office Of The Group Chair 221 Longwood Avenue, Room 108
Boston, MA
02115

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+16177328919

Website

http://www.AllianceforClinicalTrialsinOncology.org/

Alerts

Be the first to know and let us send you an email when Alliance for Clinical Trials in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.